Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma

Authors:

Abstract
No abstract available
Funding Information
  • PROSPECT (W81XWH-07-1-0306)
  • PS30 Cancer Center (P30 CA016672)

This publication has 45 references indexed in Scilit: